Voloridge Investment Management, LLC Zai Lab LTD Transaction History

Voloridge Investment Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$22.72 - $31.49 $241,150 - $334,234	10,614 New	10,614 $258,000
Q3 2021 Nov 15, 2021	SELL	$105.0 - $178.37 $1.31 Million - $2.22 Million	-12,454 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$125.11 - $180.0 $205,180 - $295,200	-1,640 Reduced 11.64%	12,454 $2.2 Million
Q1 2021 May 17, 2021	BUY	$126.27 - $191.71 $611,651 - $928,643	4,844 Added 52.37%	14,094 $1.88 Million
Q4 2020 Feb 16, 2021	SELL	$81.94 - $135.34 $4.59 Million - $7.59 Million	-56,068 Reduced 85.84%	9,250 $1.25 Million
Q3 2020 Nov 16, 2020	BUY	$73.3 - $89.48 $4.79 Million - $5.84 Million	65,318 New	65,318 $5.43 Million
Q1 2020 May 15, 2020	SELL	$39.1 - $62.9 $463,374 - $745,427	-11,851 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$29.79 - $43.06 $353,041 - $510,304	11,851 New	11,851 $493,000

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.43B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.